| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 383-387, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JM Streitz Jr, CW Andrews Jr and FH Ellis Jr
Patients with Barrett's esophagus are recognized as having a high risk of
development of adenocarcinoma. Although endoscopic surveillance of these
patients is commonly practiced, its benefits have not been proved. This
study was undertaken to examine the effect of endoscopic surveillance on
the stage of resected carcinoma arising in Barrett's esophagus and the
effect on postoperative survival. Between 1973 and 1991, 77 patients with
adenocarcinoma were seen by us, and 19 of them were under endoscopic
surveillance. The 19 patients underwent endoscopic biopsies at 1-month to
4-year intervals (median 6 months). All but one patient underwent
esophagogastrectomy when severe dysplasia or invasive carcinoma was
detected. The stages of the resected carcinomas in the group under
surveillance compared with the group not under surveillance were
significantly different, 58% of the patients under surveillance having
stages 0 and I disease and 21% having stage III disease compared with 17%
of the patients not under surveillance having stages 0 and I disease and
47% having stage III disease (p = 0.006). The 5-year actuarial survival of
patients undergoing routine surveillance was 62% and of patients not under
surveillance, 20% (p = 0.007). Endoscopic surveillance of patients with
benign Barrett's esophagus permits detection of carcinoma at an early stage
and improves long-term survival after resection for severe dysplasia and
invasive carcinoma.
ARTICLES
Endoscopic surveillance of Barrett's esophagus. Does it help?
Department of Thoracic and Cardiovascular Surgery, Lahey Clinic Medical Center, Burlington, MA 01805.
This article has been cited by other articles:
|
|
 |
|
  P Lao-Sirieix, A Boussioutas, S R Kadri, M O'Donovan, I Debiram, M Das, L Harihar, and R C Fitzgerald Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic Gut, November 1, 2009; 58(11): 1451 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jin, Y. Cheng, W. Gu, Y. Zheng, F. Sato, Y. Mori, A. V. Olaru, B. C. Paun, J. Yang, T. Kan, et al. A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus Cancer Res., May 15, 2009; 69(10): 4112 - 4115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yousef, C. Cardwell, M. M. Cantwell, K. Galway, B. T. Johnston, and L. Murray The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis Am. J. Epidemiol., August 1, 2008; 168(3): 237 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Larghi, P G Lecca, and G Costamagna High-resolution narrow band imaging endoscopy Gut, July 1, 2008; 57(7): 976 - 986. [Full Text] [PDF]
|
|
|
|
|
|
L Murray, A Sedo, M Scott, D McManus, J M Sloan, L J Hardie, D Forman, and C P Wild TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort Gut, October 1, 2006; 55(10): 1390 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Wongsurawat, J. C. Finley, P. C. Galipeau, C. A. Sanchez, C. C. Maley, X. Li, P. L. Blount, R. D. Odze, P. S. Rabinovitch, and B. J. Reid Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Agarwal, S. G. Swisher, J. Ajani, K. Kelly, R. R. Komaki, E. Abu-Hamda, A. M. Correa, and J. A. Roth Differential Response to Preoperative Chemoradiation and Surgery in Esophageal Adenocarcinomas Based on Presence of Barrett's Esophagus and Symptomatic Gastroesophageal Reflux Ann. Thorac. Surg., May 1, 2005; 79(5): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wilkins and R. A. Gillies Office-Based Unsedated Ultrathin Esophagoscopy in a Primary Care Setting Ann. Fam. Med, March 1, 2005; 3(2): 126 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Sharma and E I Sidorenko Are screening and surveillance for Barrett's oesophagus really worthwhile? Gut, March 1, 2005; 54(suppl_1): i27 - i32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N J Shaheen, J M Inadomi, B F Overholt, and P Sharma What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis Gut, December 1, 2004; 53(12): 1736 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Chang and D. A. Katzka Gastroesophageal Reflux Disease, Barrett Esophagus, and Esophageal Adenocarcinoma Arch Intern Med, July 26, 2004; 164(14): 1482 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. McManus, A. Olaru, and S. J. Meltzer Biomarkers of Esophageal Adenocarcinoma and Barrett's Esophagus Cancer Res., March 1, 2004; 64(5): 1561 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Rudolph, T. L. Vaughan, A. R. Kristal, P. L. Blount, D. S. Levine, P. C. Galipeau, L. J. Prevo, C. A. Sanchez, P. S. Rabinovitch, and B. J. Reid Serum Selenium Levels in Relation to Markers of Neoplastic Progression Among Persons With Barrett's Esophagus J Natl Cancer Inst, May 21, 2003; 95(10): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A M. Fendrick, and N. Vakil Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis Ann Intern Med, February 4, 2003; 138(3): 176 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K K Basu and J S de Caestecker Surveillance in Barrett's oesophagus: a personal view Postgrad. Med. J., May 1, 2002; 78(919): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shaheen and D. F. Ransohoff Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review JAMA, April 17, 2002; 287(15): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Spechler Barrett's Esophagus N. Engl. J. Med., March 14, 2002; 346(11): 836 - 842. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Klaus and R. A. Hinder Indications for Antireflux Surgery in Barrett's Surgical Innovation, December 1, 2001; 8(4): 234 - 239. [Abstract] [PDF]
|
|
|
|
|
|
R. E. Rudolph, T. L. Vaughan, B. E. Storer, R. C. Haggitt, P. S. Rabinovitch, D. S. Levine, and B. J. Reid Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus Ann Intern Med, April 18, 2000; 132(8): 612 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Morales and R. E. Sampliner Barrett's Esophagus: Update on Screening, Surveillance, and Treatment Arch Intern Med, July 12, 1999; 159(13): 1411 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Jankowski, N. A. Wright, S. J. Meltzer, G. Triadafilopoulos, K. Geboes, A. G. Casson, D. Kerr, and L. S. Young Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus Am. J. Pathol., April 1, 1999; 154(4): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Reed Surgical Management of Esophageal Carcinoma Oncologist, April 1, 1999; 4(2): 95 - 105. [Abstract] [Full Text]
|
|
|
|
|
|
J W van Sandick, J J B van Lanschot, B W Kuiken, G N J Tytgat, G J A Offerhaus, and H Obertop Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut, August 1, 1998; 43(2): 216 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Macdonald, A C Wicks, and R J Playford Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital Gut, September 1, 1997; 41(3): 303 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Little Barrett's Esophagus Ann. Thorac. Surg., July 1, 1996; 62(1): 315 - 315. [Full Text]
|
|
|
|
 |
|
 C. G. Bremner Invited Commentary Arch Surg, July 1, 1996; 131(7): 713 - 713. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Streitz Jr, F. H. Ellis Jr, S. P. Gibb, and G. M. Heatley Achalasia and Squamous Cell Carcinoma of the Esophagus: Analysis of 241 Patients Ann. Thorac. Surg., June 1, 1995; 59(6): 1604 - 1609. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Nikulasson, C. W. Andrews JR, H. Goldman, J. Hallgrimsson, B. Cukor, A. M. Mercurio, and G. D. Steele JR Sucrase-Isomaltase Expression in Dysplasia Associated With Barrett's Esophagus and Chronic Gastritis International Journal of Surgical Pathology, April 1, 1995; 2(4): 281 - 286. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Peters, G. W. B. Clark, A. P. Ireland, P. Chandrasoma, T. C. Smyrk, and T. R. DeMeester Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 813 - 822. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
